Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer.

ABSTRACT:

SUBMITTER: Alves CL 

PROVIDER: S-EPMC8446011 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature